Jonathan I. Lieber - Sep 20, 2021 Form 4 Insider Report for APPLIED GENETIC TECHNOLOGIES CORP (AGTC)

Role
Chief Financial Officer
Signature
/s/ Stacie S. Aarestad, Attorney-in-fact
Stock symbol
AGTC
Transactions as of
Sep 20, 2021
Transactions value $
$0
Form type
4
Date filed
9/21/2021, 09:25 PM
Next filing
Jan 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGTC Stock Option (right to buy) Award $0 +202K $0.00 202K Sep 20, 2021 Common Stock 202K $3.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date.